BLB&B Advisors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,888
Closed -$336K 253
2021
Q4
$336K Sell
2,888
-3,491
-55% -$411K 0.02% 209
2021
Q3
$766K Sell
6,379
-2,058
-24% -$240K 0.05% 150
2021
Q2
$1.01M Sell
8,437
-6,250
-43% -$686K 0.07% 122
2021
Q1
$1.46M Sell
14,687
-33,727
-70% -$3.39M 0.11% 102
2020
Q4
$4.84M Buy
48,414
+3,429
+8% +$363K 0.39% 66
2020
Q3
$4.93M Buy
44,985
+282
+0.6% +$31.4K 0.5% 60
2020
Q2
$4.73M Sell
44,703
-3,206
-7% -$331K 0.51% 61
2020
Q1
$4.28M Sell
47,909
-761
-2% -$71.6K 0.56% 59
2019
Q4
$4.85M Sell
48,670
-865
-2% -$81.4K 0.5% 54
2019
Q3
$4.42M Sell
49,535
-3,507
-7% -$304K 0.5% 56
2019
Q2
$4.38M Sell
53,042
-750
-1% -$58.8K 0.5% 53
2019
Q1
$4.35M Buy
53,792
+7,238
+16% +$571K 0.51% 50
2018
Q4
$3.54M Buy
46,554
+1,931
+4% +$151K 0.49% 55
2018
Q3
$3.53M Buy
44,623
+9,688
+28% +$733K 0.44% 63
2018
Q2
$2.45M Buy
34,935
+5,079
+17% +$365K 0.33% 84
2018
Q1
$2.09M Buy
29,856
+2,431
+9% +$168K 0.28% 93
2017
Q4
$1.9M Buy
27,425
+15,694
+134% +$1.06M 0.27% 92
2017
Q3
$795K Buy
+11,731
New +$741K 0.12% 149

Other funds holding AZN